ArticleJournal of nanobiotechnology2024

EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapy.

Zhenggang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.